Pinsheng Han
Changhongjie, 300192, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Activation of methionine metabolism mediated by HNF4α confers ferroptosis resistance in hepatocellular carcinoma.
Journal: Cell death discovery
Published: November 26, 2025
Modeling ischemic-type biliary lesion in vitro using human expandable intrahepatic cholangiocyte organoids.
Journal: Frontiers in bioengineering and biotechnology
Published: November 24, 2025
Ultrasound-activated piezoelectric BZT Nanocubes mediate direct Piezocatalytic killing and reverse immunosuppressive tumor microenvironment for effective hepatocellular carcinoma therapy.
Journal: International immunopharmacology
Published: October 15, 2025
Generation and applications of an expandable and mature hiPSC-derived liver organoid.
Journal: Acta pharmaceutica Sinica. B
Published: June 25, 2025
Cholangiocarcinoma-derived SPP1 drives tumor progression by inducing macrophage chemotaxis and M2 polarization.
Journal: International immunopharmacology
Published: June 02, 2025
Mechanism and regulation of mitophagy in liver diseases: a review.
Journal: Frontiers in cell and developmental biology
Published: April 20, 2025
Discovery of Potential Scaffolds for Methionine Adenosyltransferase 2A (MAT2A) Inhibitors: Virtual Screening, Synthesis, and Biological Evaluation.
Journal: Molecules (Basel, Switzerland)
Published: March 31, 2025
Construction of vascularized liver microtissues recapitulates angiocrine-mediated hepatocytes maturation and enhances therapeutic efficacy for acute liver failure.
Journal: Bioactive materials
Published: December 25, 2024
TWEAK is an activator of Hippo-YAP signaling protecting against hepatic Ischemia/ reperfusion injury.
Journal: International immunopharmacology
Published: July 31, 2024
Modeling hepatic steatosis with human adult stem cell-derived liver organoids.
Journal: iScience
Published: May 18, 2024
Last Updated: 09/26/2026